AHA Hypertension Scientific Sessions 2026

Richmond Pharmacology is excited to join the AHA Hypertension Scientific Sessions 2026 in Arlington, USA, on 07 – 11  October 2026.

Uniting global experts in hypertension research and cardiovascular health, this meeting serves as a platform for groundbreaking science, clinical insights, and collaborative strategies to improve patient outcomes worldwide.

Representing Richmond Pharmacology

• Jörg Taubel, Chief Executive Officer

We look forward to connecting with attendees to discuss Richmond’s expertise in:

• Innovations in hypertension drug development

• Clinical trial design for complex cardiovascular conditions

• Regulatory pathways for novel therapies

• Patient-centric approaches and recruitment strategies

• Collaboration between academia, industry, and regulators

Connect With Us

If you are attending AHA Hypertension Scientific Sessions 2026 and would like to explore partnership or development opportunities email us at:

📧 fasteranswers@richmondpharmacology.com

‍